Many parents struggle deciding whether their middle or high school aged child should stay home from school if they don’t feel well, a new national poll suggests.
‘Practice Changing’ Trial for Inoperable Locally Advanced NSCLC
CHICAGO — Patients without disease progression following chemoradiotherapy for unresectable stage III non-small cell lung cancer (NSCLC) should receive osimertinib (Tagrisso) if they harbor EGFR
June 3, 2024